Details of the Drug Combinations

General Information of This Drug (ID: DMBY56U)

Drug Name

EXISULIND DMBY56U

Synonyms

Aposulind; Aptosyn; Sulindac sulfone; FGN-1; Prevatac (former Brand Name); Exisulind; (Z)-5-Fluoro-2-methyl-1-[4-(methylsulfonyl)benzylidene]-1H-indene-3-acetic acid

Indication

Disease Entry	ICD 11	Status	REF
Colorectal cancer	2B91.Z	Phase 3	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

2 Clinical Trial Drug Combination(s) Consisting of This drug

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
EXISULIND + Capecitabine	DCAO9ZT	Capecitabine	Breast Neoplasms	[2]
Gonadorelin + EXISULIND	DCUFLUR	Gonadorelin	Prostate Cancer	[3]
------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT00085826) A Phase III Study of the Efficacy of Taxotere/Aptosyn Versus Taxotere/Placebo in Non-Small Cell Lung Cancer Patients. U.S. National Institutes of Health.
2	ClinicalTrials.gov (NCT00037609) Safety, Efficacy and Pharmacokinetic Between Capecitabine and Exisulind in Metastatic Breast Cancer Patients
3	ClinicalTrials.gov (NCT00283803) Exisulind and Intermittent Androgen Suppression (ADT) in Biochemical Relapsed Prostate Cancer